SOLARA (22)
| Date | Circular | Tags | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
NSE lists further equity shares issued under ESOP schemes by 27 companies including Aditya Birla Capital, Aptus Value Housing Finance, … | |||||||||||||||
NSE lists further equity shares issued under ESOP schemes by 27 companies including Aditya Birla Capital, Aptus Value Housing Finance, Chalet Hotels, and others, effective December 17, 2025.
| |||||||||||||||
BSE announces listing and admission to trading of equity shares issued under ESOP/ESOS schemes by 29 companies, effective December 17, 2025. | |||||||||||||||
BSE announces listing and admission to trading of equity shares issued under ESOP/ESOS schemes by 29 companies, effective December 17, 2025.
| |||||||||||||||
BSE announces listing and admission for trading of new securities issued under ESOP/ESOS schemes by 29 companies, effective December 17, … | |||||||||||||||
BSE announces listing and admission for trading of new securities issued under ESOP/ESOS schemes by 29 companies, effective December 17, 2025.
| |||||||||||||||
BSE announces listing and trading commencement of additional equity shares issued under ESOP/ESOS schemes by 29 companies effective December … | |||||||||||||||
BSE announces listing and trading commencement of additional equity shares issued under ESOP/ESOS schemes by 29 companies effective December 17, 2025.
| |||||||||||||||
BSE surveillance requested clarifications from Solara Active Pharma Sciences, Bombay Burmah Trading Corporation, and Capital India Finance … | |||||||||||||||
BSE surveillance requested clarifications from Solara Active Pharma Sciences, Bombay Burmah Trading Corporation, and Capital India Finance regarding significant increase in trading volumes. All companies confirmed compliance with disclosure requirements and stated no price-sensitive information was withheld.
| |||||||||||||||
Three companies (Solara Active Pharma Sciences, Bombay Burmah Trading Corporation, and Capital India Finance) clarified to BSE that they … | |||||||||||||||
Three companies (Solara Active Pharma Sciences, Bombay Burmah Trading Corporation, and Capital India Finance) clarified to BSE that they have disclosed all material information and have no undisclosed price-sensitive information regarding recent volume spikes in their securities.
| |||||||||||||||
List of securities and quantities involved in BSE's demat auction for settlement number 756 dated November 17, 2025. | |||||||||||||||
List of securities and quantities involved in BSE's demat auction for settlement number 756 dated November 17, 2025.
| |||||||||||||||
BSE announces demat auction for settlement number 756 covering 94 scrips with various quantities to be auctioned. | |||||||||||||||
BSE announces demat auction for settlement number 756 covering 94 scrips with various quantities to be auctioned.
| |||||||||||||||
BSE demat auction listing 95 securities across 47 scrips scheduled for settlement number 756 dated November 17, 2025. | |||||||||||||||
BSE demat auction listing 95 securities across 47 scrips scheduled for settlement number 756 dated November 17, 2025.
| |||||||||||||||
BSE Demat Auction Settlement No. 756 listing securities and quantities for auction settlement dated November 17, 2025. | |||||||||||||||
BSE Demat Auction Settlement No. 756 listing securities and quantities for auction settlement dated November 17, 2025.
| |||||||||||||||